Quantcast

Latest Macular degeneration Stories

2014-03-03 04:22:41

TARRYTOWN, N.Y., March 3, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA(®) (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare (MHLW). "Clinically significant DME is a leading cause of vision loss in the working-age...

2014-02-24 08:27:50

TARRYTOWN, N.Y., Feb. 24, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company's supplemental Biologics License Application (sBLA) for EYLEA(®) (aflibercept) Injection for the treatment of Macular Edema following Branch Retinal Vein Occlusion (BRVO). Under the Prescription Drug User Fee Act (PDUFA), the goal for a standard review of an sBLA is ten months from...

2014-02-20 16:26:52

WEST CONSHOHOCKEN, Pa., Feb. 20, 2014 /PRNewswire-USNewswire/ --The Macula Vision Research Foundation (MVRF) will host a FREE SupportSight(SM) seminar on February 25, 2014 about the latest in research, treatment, patient care and early detection, technology and coping with vision impairment. WHO: MVRF - a national nonprofit focused on finding a cure for macular degeneration and other retinal diseases. To reach this goal, MVRF funds groundbreaking research projects conducted by...

2014-02-20 16:25:18

Researchers also find a slight, though statistically non-significant, increase in age-related macular degeneration risk among multivitamin users; call for further study SAN FRANCISCO, Feb. 20, 2014 /PRNewswire-USNewswire/ -- Long-term daily multivitamin supplement use may lower cataract risk in men, according to a study of nearly 15,000 male physicians published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. (Logo:...

2014-02-18 08:27:28

Free AMD Guide Helps Patients Understand Risks, Proactive Measures for Eye Health ST. LOUIS, Feb. 18, 2014 /PRNewswire/ -- February is National AMD/Low Vision Awareness Month. Due to the aging Baby Boomer population, AMD, or Age-related Macular Degeneration, is expected to double by the year 2020, and patient education is critical in fighting vision loss and preserving healthy vision. EyePromise® eye vitamins is offering a complimentary patient education guide, "Getting Clear on...

2014-02-14 23:03:23

New national partnership to increase education and outreach on topics of macular degeneration, latest research, prevention, treatment, as well as low vision technology and adaptive aids to improve quality of life. Vista, CA, Conshohocken, PA, (PRWEB) February 14, 2014 The Macula Vision Research Foundation (MVRF) and Optelec have formed a unique partnership of industry and philanthropy to benefit more than 11 million people in the United States with age-related macular degeneration (AMD)...

Exercise Can Help Reduce Or Slow Vision Loss
2014-02-12 12:23:58

Brett Smith for redOrbit.com - Your Universe Online While it may seem unrelated to eye function, physical exercise can actually help to protect the structure and function of nerve cells in the retina after injury – according to a new study in The Journal of Neuroscience. The study indicated that exercising may be able to hamper the advancement of retinal degenerative diseases, such as age-related macular degeneration. “This is the first report of simple exercise having a direct...

2014-02-10 23:24:41

Age-Related Macular Degeneration (AMD) is the leading cause of severe vision loss in people over the age of 55 and it roughly affects 15 million Americans. Mechanicsburg, PA (PRWEB) February 10, 2014 Age-Related Macular Degeneration (AMD) is the leading cause of severe vision loss in people over the age of 55 and it roughly affects 15 million Americans. According to the National Eye Institute, AMD occurs when the small central portion of the retina, known as the macula, deteriorates....

2014-02-10 08:26:04

TARRYTOWN, N.Y., Feb. 10, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that in the Phase 3 VISTA-DME trial of EYLEA(®) (aflibercept) Injection for the treatment of diabetic macular edema (DME), EYLEA 2 milligrams (mg) dosed monthly (2Q4) and EYLEA 2 mg dosed every two months (after 5 initial monthly injections, 2Q8) showed a sustained improvement from baseline in best corrected visual acuity (BCVA) at week 100, compared to...

2014-02-06 08:29:32

American Academy of Ophthalmology advises that early detection and today's treatments for common eye disease among seniors can help stop vision loss SAN FRANCISCO, Feb. 6, 2014 /PRNewswire/ -- While age-related macular degeneration (AMD) is the leading cause of new cases of blindness in Americans age 65 and older[1], seniors who develop AMD should not consider blindness in advanced age to be inevitable, according to the American Academy of Ophthalmology. During AMD Awareness Month, the...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related